Efsubaglutide Alfa
Metabolic Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Metabolic Surgery cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Phentermine Wake Forest University Health Sciences | Phase 2 | B |
Topamax Wake Forest University Health Sciences | Phase 2 | B |
Same molecule, other indications
Efsubaglutide Alfa is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →